HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alessandra Bitto Selected Research

Dystrophin

9/2015Modulation of neuronal nitric oxide synthase and apoptosis by the isoflavone genistein in Mdx mice.
3/2006Nuclear factor kappa-B blockade reduces skeletal muscle degeneration and enhances muscle function in Mdx mice.
3/2006Lipid peroxidation inhibition blunts nuclear factor-kappaB activation, reduces skeletal muscle degeneration, and enhances muscle function in mdx mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Alessandra Bitto Research Topics

Disease

21Wounds and Injuries (Trauma)
10/2021 - 08/2004
16Inflammation (Inflammations)
02/2023 - 07/2010
13Ischemia
10/2021 - 10/2004
11Neoplasms (Cancer)
08/2023 - 04/2004
11Reperfusion Injury
01/2016 - 04/2004
10Osteoporosis
09/2023 - 04/2004
10Necrosis
02/2021 - 03/2006
9Systemic Scleroderma (Systemic Sclerosis)
12/2022 - 08/2013
9Ischemic Stroke
04/2012 - 03/2006
8Atherosclerosis
12/2022 - 05/2004
7Multiple Myeloma
11/2023 - 01/2016
7Fibrosis (Cirrhosis)
06/2023 - 08/2013
7Sepsis (Septicemia)
04/2023 - 07/2010
7Cardiovascular Diseases (Cardiovascular Disease)
01/2023 - 04/2004
7Shock
04/2012 - 11/2005
7Brain Ischemia (Cerebral Ischemia)
04/2012 - 03/2006
6Pulmonary Fibrosis (Fibrosing Alveolitis)
12/2022 - 08/2013
6Metabolic Syndrome (Dysmetabolic Syndrome X)
06/2017 - 03/2009
5Bone Resorption
09/2023 - 01/2004
5Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
01/2021 - 03/2006
5Insulin Resistance
01/2017 - 03/2005
5Stroke (Strokes)
11/2011 - 05/2006
4Colitis
01/2022 - 01/2016
4Hypoxia (Hypoxemia)
10/2021 - 10/2009
4Traumatic Brain Injuries (Traumatic Brain Injury)
08/2020 - 03/2012
4Burns
01/2015 - 07/2005
4Spermatic Cord Torsion (Testicular Torsion)
04/2009 - 10/2004
3Neurodegenerative Diseases (Neurodegenerative Disease)
10/2023 - 03/2014
3Neuroinflammatory Diseases
06/2023 - 08/2020
3Pneumoperitoneum
01/2023 - 04/2012
3Heart Failure
04/2022 - 01/2021
3COVID-19
04/2022 - 04/2021
3Hypertension (High Blood Pressure)
01/2022 - 11/2004
3Osteoarthritis
01/2022 - 01/2011
3Obesity
07/2021 - 11/2004
3Chronic Disease (Chronic Diseases)
10/2020 - 04/2004
3Weight Loss (Weight Reduction)
08/2020 - 10/2016
3Ulcer
01/2018 - 10/2009
3Edema (Dropsy)
01/2018 - 07/2008

Drug/Important Bio-Agent (IBA)

26Proteins (Proteins, Gene)FDA Link
01/2023 - 08/2004
21GenisteinIBA
09/2023 - 04/2004
19Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2018 - 08/2004
14salicylhydroxamic acid (SHAM)IBA
02/2020 - 07/2004
14MelanocortinsIBA
10/2014 - 11/2005
14Messenger RNA (mRNA)IBA
12/2013 - 09/2004
13Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2015 - 03/2006
10flavocoxidIBA
04/2023 - 12/2009
10PolydeoxyribonucleotidesIBA
01/2022 - 05/2008
10Purinergic P1 Receptors (Adenosine Receptor)IBA
01/2022 - 10/2009
9IsoflavonesIBA
09/2023 - 08/2007
9Phosphotransferases (Kinase)IBA
01/2018 - 02/2005
8Reactive Oxygen Species (Oxygen Radicals)IBA
10/2023 - 01/2011
8NF-kappa B (NF-kB)IBA
11/2010 - 03/2006
7AntioxidantsIBA
10/2023 - 10/2004
7CytokinesIBA
06/2023 - 03/2003
7InflammasomesIBA
08/2020 - 05/2014
7Mitogen-Activated Protein KinasesIBA
11/2014 - 02/2005
7Peptides (Polypeptides)IBA
04/2012 - 11/2005
6GlucocorticoidsIBA
09/2023 - 06/2009
6CateninsIBA
10/2022 - 01/2018
6Interleukin-6 (Interleukin 6)IBA
04/2022 - 04/2009
6Hormones (Hormone)IBA
01/2020 - 04/2004
6Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
11/2015 - 11/2005
5caryophylleneIBA
11/2023 - 01/2019
5Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2022 - 04/2006
5Melanocyte-Stimulating Hormones (MSH)IBA
03/2014 - 02/2011
5Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
02/2012 - 07/2005
4LycopeneIBA
12/2022 - 10/2011
4Adenosine A2A Receptor (Adenosine A2A Receptors)IBA
10/2021 - 03/2011
4CollagenIBA
10/2021 - 08/2004
4Biomarkers (Surrogate Marker)IBA
08/2020 - 08/2013
4LipopolysaccharidesIBA
01/2019 - 07/2008
4oxidized low density lipoproteinIBA
01/2016 - 05/2004
4EnzymesIBA
11/2014 - 05/2004
4Type 4 Melanocortin Receptor (Melanocortin-4 Receptor)IBA
10/2014 - 03/2006
4Glucose (Dextrose)FDA LinkGeneric
10/2012 - 03/2005
4Neuroprotective AgentsIBA
03/2012 - 03/2006
4Interleukin-10 (Interleukin 10)IBA
03/2012 - 07/2010
4alpha-MSHIBA
08/2009 - 03/2006
4Mitogen-Activated Protein Kinase 3IBA
02/2009 - 10/2004
4JNK Mitogen-Activated Protein KinasesIBA
12/2007 - 10/2004
3CadmiumIBA
10/2023 - 11/2015
3Peroxisome Proliferator-Activated Receptors (PPAR)IBA
02/2023 - 04/2009
3Adenosine (Adenocard)FDA LinkGeneric
01/2023 - 11/2011
3Transforming Growth Factors (Transforming Growth Factor)IBA
01/2023 - 09/2013
3PropylthiouracilFDA Link
12/2022 - 09/2013
3CurcuminIBA
01/2022 - 01/2019
3Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2021 - 02/2008
3dinitrobenzenesulfonic acidIBA
10/2020 - 01/2016
32,4-dinitrofluorobenzene sulfonic acidIBA
10/2020 - 01/2016
3Interleukin-18 (Interleukin 18)IBA
08/2020 - 11/2010
3NitritesIBA
02/2018 - 07/2005
3Malondialdehyde (Propanedial)IBA
02/2018 - 11/2015
3Simvastatin (Zocor)FDA LinkGeneric
01/2016 - 02/2008
3Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
01/2016 - 02/2005
3DystrophinIBA
09/2015 - 03/2006

Therapy/Procedure

7Therapeutics
08/2023 - 10/2016
4Injections
09/2013 - 10/2004
3Punctures
01/2015 - 04/2012
3Ligation
01/2015 - 04/2012